Proteoglycans: many forms and many functions

Proteoglycans are produced by most eukaryotic cells and are versatile components of pericellular and extracellular matrices. They belong to many different protein families. Their functions vary from the physical effects of the proteoglycan aggrecan, which binds with link protein to hyaluronan to form multi‐molecular aggregates in cartilage; to the intercalated membrane protein CD44 that has a proteoglycan form and is a receptor and a cell‐binding site for hyaluronan; to heparan sulfate proteoglycans of the syndecan and other families that provide matrix binding sites and cell‐surface receptors for growth factors such as fibroblast growth factor (FGF). One feature that recurs in proteoglycan biology is that their structure is open to extensive modulation during cellular expression. Examples of protein changes are known, but a major source of structural variation is in the glycosaminoglycan chains. The number of chains and their length can vary, as well as their pattern of sulfation. This may result in the switching of different chain types with different properties, e.g., chondroitin sulfate and heparan sulfate, and it may also result in the selective expression of sulfated chain sequences that have specific functions. The control of glycosaminoglycan structure is not well understood, but it does appear to be used to change the properties of proteoglycans to suit different biological needs. Proteoglycan forms of proteins are thus important modifiers of the organization of the pericellular and extracellular matrices and modulators of the processes that occur there.—Hardingham, T. E., Fosang, A. J. Protoglycans: many forms and many functions. FASEB J. 6: 861‐870; 1992.

[1]  L. Picker,et al.  A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins , 1989, Cell.

[2]  W. Carter,et al.  Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons , 1991, The Journal of cell biology.

[3]  A. Plaas,et al.  Identification of the keratan sulfate attachment sites on bovine fibromodulin. , 1990, The Journal of biological chemistry.

[4]  D. Rifkin,et al.  Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. , 1990 .

[5]  M. Salmivirta,et al.  Binding of human syndecan to extracellular matrix proteins. , 1990, The Journal of biological chemistry.

[6]  M. Amiot,et al.  The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells. , 1991, The EMBO journal.

[7]  R. Thompson,et al.  Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits. , 1990, Growth factors.

[8]  P. Goetinck,et al.  Nanomelic chondrocytes synthesize a glycoprotein related to chondroitin sulfate proteoglycan core protein. , 1988, The Journal of biological chemistry.

[9]  J. Sandy,et al.  Acquisition of hyaluronate-binding affinity in vivo by newly synthesized cartilage proteoglycans. , 1989, The Biochemical journal.

[10]  E. Ruoslahti,et al.  Multiple domains of the large fibroblast proteoglycan, versican. , 1989, The EMBO journal.

[11]  L. Vaughan,et al.  Identification of the type IX collagen polypeptide chains. The alpha 2(IX) polypeptide carries the chondroitin sulfate chain(s). , 1986, The Journal of biological chemistry.

[12]  K. Doege,et al.  Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. , 1991, The Journal of biological chemistry.

[13]  J. Gallagher The extended family of proteoglycans: social residents of the pericellular zone. , 1989, Current opinion in cell biology.

[14]  C. Esmon,et al.  The roles of protein C and thrombomodulin in the regulation of blood coagulation. , 1984, The Journal of biological chemistry.

[15]  T. Hardingham,et al.  Immunoglobulin fold and tandem repeat structures in proteoglycan N-terminal domains and link protein. , 1989, Journal of molecular biology.

[16]  R. Abe,et al.  Characterization of autoantibody-secreting B cells in mice undergoing stimulatory (chronic) graft-versus-host reactions. Identification of a CD44hi population that binds specifically to hyaluronate. , 1991, Journal of immunology.

[17]  A. Ratcliffe,et al.  Modulation of native chondroitin sulphate structure in tissue development and in disease. , 1990, Journal of cell science.

[18]  T. Hardingham,et al.  Proteoglycans of articular cartilage: changes in aging and in joint disease. , 1990, Seminars in arthritis and rheumatism.

[19]  E. Butcher,et al.  The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins [published erratum appears in J Cell Biol 1991 Feb;112(3):following 513] , 1990, The Journal of cell biology.

[20]  J. Scott,et al.  Identification of specific binding sites for keratan sulphate proteoglycans and chondroitin-dermatan sulphate proteoglycans on collagen fibrils in cornea by the use of cupromeronic blue in 'critical-electrolyte-concentration' techniques. , 1988, The Biochemical journal.

[21]  M. Young,et al.  Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. , 1989, The Journal of biological chemistry.

[22]  K. Sakaguchi,et al.  Identification of heparan sulfate proteoglycan as a high affinity receptor for acidic fibroblast growth factor (aFGF) in a parathyroid cell line. , 1991, Journal of Biological Chemistry.

[23]  D. Wright,et al.  Vitreous humor of chicken contains two fibrillar systems: an analysis of their structure. , 1988, Journal of ultrastructure and molecular structure research.

[24]  D. Eyre,et al.  Collagen type IX: Evidence for covalent linkages to type II collagen in cartilage , 1987, FEBS letters.

[25]  P. Jaakkola,et al.  Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans. , 1990, The Journal of biological chemistry.

[26]  I. Weissman,et al.  The mouse lymph node homing receptor is identical with the lymphocyte cell surface marker Ly-22: Role of the EGF domain in endothelial binding , 1990, Cell.

[27]  Erkki Ruoslahti,et al.  Proteoglycans as modulators of growth factor activities , 1991, Cell.

[28]  U. Lindahl,et al.  Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin proteoglycan. , 1990, The Journal of biological chemistry.

[29]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[30]  K. Kobayashi,et al.  Occurrence in chick embryo vitreous humor of a type IX collagen proteoglycan with an extraordinarily large chondroitin sulfate chain and short alpha 1 polypeptide. , 1990, The Journal of biological chemistry.

[31]  L. Peltonen,et al.  Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome. , 1990, The Journal of biological chemistry.

[32]  T. Hardingham,et al.  Isolation of the N-terminal globular protein domains from cartilage proteoglycans. Identification of G2 domain and its lack of interaction with hyaluronate and link protein. , 1989, The Biochemical journal.

[33]  K. Drickamer,et al.  A segment of the cartilage proteoglycan core protein has lectin-like activity. , 1988, The Journal of biological chemistry.

[34]  E. Ruoslahti Structure and biology of proteoglycans. , 1988, Annual review of cell biology.

[35]  J. Wagner,et al.  Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half‐life , 1989, Journal of cellular physiology.

[36]  A. Rapraeger Transforming growth factor (type beta) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia , 1989, The Journal of cell biology.

[37]  D. Heinegård,et al.  Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. , 1984, The Biochemical journal.